Paxlovid, which combines a new Pfizer pill with the old antiviral ritonavir, is currently authorised for use in the first days of a COVID infection to prevent severe disease in high-risk patients.Paxlovid, which combines a new Pfizer pill with the old antiviral ritonavir, is currently authorised for use in the first days of a COVID infection to prevent severe disease in high-risk patients.
According to details of the study, posted on Clinicaltrials.gov, the randomised, placebo-controlled trial will test Pfizer’s treatment or a placebo in 1 700 volunteers aged 18 and older. The trial will investigate a leading theory of the cause of long COVID, which holds that fragments of the virus persist in the tissues of some individuals, causing prolonged symptoms.
I was scammed through Bitcoin couple of months ago, I started hating Bitcoin until I was introduced to joshua_encrypt and I gave Bitcoin trading another try, I successfully withdrew $35,000 after two weeks of trading, am so grateful joshua_encrypt thank you